224 related articles for article (PubMed ID: 30018044)
21. Successful treatment of advanced alveolar soft part sarcoma with camrelizumab combined with apatinib: a case report.
Xu Z; Zhang Y; Yu YH
Ann Palliat Med; 2021 Jan; 10(1):785-792. PubMed ID: 33545800
[TBL] [Abstract][Full Text] [Related]
22. Response to sunitinib malate in advanced alveolar soft part sarcoma.
Stacchiotti S; Tamborini E; Marrari A; Brich S; Rota SA; Orsenigo M; Crippa F; Morosi C; Gronchi A; Pierotti MA; Casali PG; Pilotti S
Clin Cancer Res; 2009 Feb; 15(3):1096-104. PubMed ID: 19188185
[TBL] [Abstract][Full Text] [Related]
23. High-resolution array CGH and gene expression profiling of alveolar soft part sarcoma.
Selvarajah S; Pyne S; Chen E; Sompallae R; Ligon AH; Nielsen GP; Dranoff G; Stack E; Loda M; Flavin R
Clin Cancer Res; 2014 Mar; 20(6):1521-30. PubMed ID: 24493828
[TBL] [Abstract][Full Text] [Related]
24. Effective treatment of advanced alveolar soft part sarcoma with sunitinib: A case report.
Ye C; Wang J; Li W; Yuan M; Chai Y
Medicine (Baltimore); 2018 Dec; 97(51):e13584. PubMed ID: 30572461
[TBL] [Abstract][Full Text] [Related]
25. Expression of MET in alveolar soft part sarcoma.
Jun HJ; Lee J; Lim DH; Park JO; Ahn G; Seo SW; Sung KS; Lim DH; Yoo KH; Choi YL
Med Oncol; 2010 Jun; 27(2):459-65. PubMed ID: 19472090
[TBL] [Abstract][Full Text] [Related]
26. Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma.
Mukaihara K; Tanabe Y; Kubota D; Akaike K; Hayashi T; Mogushi K; Hosoya M; Sato S; Kobayashi E; Okubo T; Kim Y; Kohsaka S; Saito T; Kaneko K; Suehara Y
PLoS One; 2017; 12(9):e0185321. PubMed ID: 28945796
[TBL] [Abstract][Full Text] [Related]
27. Cediranib for metastatic alveolar soft part sarcoma.
Kummar S; Allen D; Monks A; Polley EC; Hose CD; Ivy SP; Turkbey IB; Lawrence S; Kinders RJ; Choyke P; Simon R; Steinberg SM; Doroshow JH; Helman L
J Clin Oncol; 2013 Jun; 31(18):2296-302. PubMed ID: 23630200
[TBL] [Abstract][Full Text] [Related]
28. Molecular Landscape in Alveolar Soft Part Sarcoma: Implications for Molecular Targeted Therapy.
Soheilifar MH; Taheri RA; Zolfaghari Emameh R; Moshtaghian A; Kooshki H; Motie MR
Biomed Pharmacother; 2018 Jul; 103():889-896. PubMed ID: 29710505
[TBL] [Abstract][Full Text] [Related]
29. Molecular analyses of cell origin and detection of circulating tumor cells in the peripheral blood in alveolar soft part sarcoma.
Hoshino M; Ogose A; Kawashima H; Izumi T; Hotta T; Hatano H; Morita T; Otsuka H; Umezu H; Yanoma S; Tsukuda M; Endo N
Cancer Genet Cytogenet; 2009 Apr; 190(2):75-80. PubMed ID: 19380023
[TBL] [Abstract][Full Text] [Related]
30. Alveolar soft part sarcoma in children and young adults: A report of 69 cases.
Flores RJ; Harrison DJ; Federman NC; Furman WL; Huh WW; Broaddus EG; Okcu MF; Venkatramani R
Pediatr Blood Cancer; 2018 May; 65(5):e26953. PubMed ID: 29350467
[TBL] [Abstract][Full Text] [Related]
31. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.
Mahoney KM; Freeman GJ; McDermott DF
Clin Ther; 2015 Apr; 37(4):764-82. PubMed ID: 25823918
[TBL] [Abstract][Full Text] [Related]
32. Technique for differentiating alveolar soft part sarcoma from other tumors in paraffin-embedded tissue: comparison of immunohistochemistry for TFE3 and CD147 and of reverse transcription polymerase chain reaction for ASPSCR1-TFE3 fusion transcript.
Tsuji K; Ishikawa Y; Imamura T
Hum Pathol; 2012 Mar; 43(3):356-63. PubMed ID: 21835426
[TBL] [Abstract][Full Text] [Related]
33. Combined immunotherapy and targeted treatment for primary alveolar soft part sarcoma of the lung: case report and literature review.
Su H; Yu C; Ma X; Song Q
Invest New Drugs; 2021 Oct; 39(5):1411-1418. PubMed ID: 33765213
[TBL] [Abstract][Full Text] [Related]
34. Alveolar soft part sarcoma--reciprocal translocation between chromosome 17q25 and Xp11. Report of a case with metastases at presentation and review of the literature.
Uppal S; Aviv H; Patterson F; Cohen S; Benevenia J; Aisner S; Hameed M
Acta Orthop Belg; 2003 Apr; 69(2):182-7. PubMed ID: 12769020
[TBL] [Abstract][Full Text] [Related]
35. [Alveolar soft part sarcoma in pediatric patients].
Paillard C; Coulomb A; Helfre S; Orbach D
Bull Cancer; 2015 Sep; 102(9):792-8. PubMed ID: 26235420
[TBL] [Abstract][Full Text] [Related]
36. Lingual alveolar soft part sarcoma responsive to pazopanib: A case report.
Yoshihiro T; Tsuchihashi K; Nio K; Arita S; Nakano T; Yasumatsu R; Jiroumaru R; Ariyama H; Kusaba H; Oda Y; Akashi K; Baba E
Medicine (Baltimore); 2017 Nov; 96(44):e8470. PubMed ID: 29095301
[TBL] [Abstract][Full Text] [Related]
37. CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients.
Ott PA; Hodi FS; Robert C
Clin Cancer Res; 2013 Oct; 19(19):5300-9. PubMed ID: 24089443
[TBL] [Abstract][Full Text] [Related]
38. A retrospective analysis of 14 consecutive Chinese patients with unresectable or metastatic alveolar soft part sarcoma treated with sunitinib.
Li T; Wang L; Wang H; Zhang S; Atikan Kawuli ; Zhang X; Luo Z; Wang C
Invest New Drugs; 2016 Dec; 34(6):701-706. PubMed ID: 27604635
[TBL] [Abstract][Full Text] [Related]
39. Crystal-deficient alveolar soft-part sarcoma with cutaneous involvement: a case report.
Kacerovska D; Michal M; Nemcova J; Vanecek T; Kreuzberg B; Mrazkova P; Koudela K; Kazakov DV
Am J Dermatopathol; 2009 May; 31(3):272-7. PubMed ID: 19384069
[TBL] [Abstract][Full Text] [Related]
40. Angiogenesis-promoting gene patterns in alveolar soft part sarcoma.
Lazar AJ; Das P; Tuvin D; Korchin B; Zhu Q; Jin Z; Warneke CL; Zhang PS; Hernandez V; Lopez-Terrada D; Pisters PW; Pollock RE; Lev D
Clin Cancer Res; 2007 Dec; 13(24):7314-21. PubMed ID: 18094412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
